Danish pharmaceutical company Novo Nordisk increased its first-quarter revenue and profit in 2025 compared to the same period ...

Novo Nordisk on Wednesday managed the unusual feat of seeing its stock price rise after reducing its earnings outlook. But ...

Novo Nordisk slashed its 2025 sales forecast citing lower-than-expected penetration of its branded GLP-1 weight loss and ...

European stock markets are poised for a mixed and cautious opening on Wednesday as investors globally turn their full ...

(Reuters) -European shares slipped on Wednesday as investors assessed a spate of corporate earnings and the latest ...

Obesity drugmaker Novo Nordisk has today downgraded its 2025 sales forecast, ending a four-year stretch of steady guidance ...